bpc-157 evidence safety review for athletes and injury treatment: Science, safety, and legal concerns BPC-157 and the Difference Between
Description
The 10 mg/day arm produced a smaller result than the 1 mg arm, not a larger one
Oral 5-Amino-1MQ can face limitations due to variable bioavailability, degradation in the gastrointestinal tract, and first-pass metabolism in the liver
Critical for calcium absorption and bone formation
Even if lab values normalize, ongoing fatigue, poor sleep, or nerve discomfort may warrant treatment continuation or adjustment
